Tracy Dixon-Salazar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tracy Dixon-Salazar has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Anup D. Patel
Department of Pediatrics, Division of Pediatric Neurology, Nationwide Children's Hospital, The Ohio State University, Columbus; and
2 shared publications - Adrian L. Rabinowicz
Neurelis, Inc., San Diego, USA
1 shared publication - Ann Hyslop
Stanford University Palo Alto USA
1 shared publication Cyndi Wright
Epilepsy Foundation Landover MD United States
1 shared publication- Dale C. Hesdorffer
Department of Epidemiology, G. H. Sergievsky Center Columbia University New York New York USA
1 shared publication - Daniel J. Friedman
Division of Cardiology, Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA
1 shared publication
Latest Publications
- Open Access
- 25 May 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 110, 42-57
Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion
- 25 May 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 110, 42-57
Open AccessProposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion
Consequences: Bench to home
Seizure clusters (also referred to as acute repetitive seizures) consist of several seizures interspersed with brief interictal periods. Seizure clusters can break down gamma-aminobutyric acidergic (GABAergic) inhibition of dentate granule cells, leading to hyperactivation. Functional changes to GABA(A) receptors, which play a vital neuroinhibitory role, can include altered GABA(A) receptor subunit trafficking and cellular localization, intracellular chloride accumulation, and dysregulation of proteins critical to chloride homeostasis. A reduction in neuroinhibition and potentiation of excitatory neurotransmission in CA1 pyramidal neurons represent pathological mechanisms that underlie seizure clusters. Benzodiazepines are well-established treatments for seizure clusters; however, there remain barriers to appropriate care. At the clinical level, there is variability in seizure cluster definitions, such as the number and/or type of seizures associated with a cluster as well as the interictal duration between seizures. This can lead to delays in diagnosis and timely treatment. There are gaps in understanding between clinicians, their patients, and caregivers regarding acute treatment for seizure clusters, such as the use of rescue medications and emergency services. This lack of consensus to define seizure clusters in addition to a lack of education for appropriate treatment can affect quality of life for patients and place a greater burden on patient families and caregivers. For patients with seizure clusters, the sense of unpredictability can lead to continuous traumatic stress, during which patients and families live with a heightened level of anxiety. Clinicians can affect patient quality of life and clinical outcomes through improved seizure cluster education and treatment, such as the development and implementation of a personalized seizure action plan as well as prescriptions for suitable rescue medications indicated for seizure clusters and instructions for their proper use. In all, the combination of targeted therapy along with patient education and support can improve quality of life.
Consequences: Bench to home
Seizure clusters (also referred to as acute repetitive seizures) consist of several seizures interspersed with brief interictal periods. Seizure clusters can break down gamma-aminobutyric acidergic (GABAergic) inhibition of dentate granule cells, leading to hyperactivation. Functional changes to GABA(A) receptors, which play a vital neuroinhibitory role, can include altered GABA(A) receptor subunit trafficking and cellular localization, intracellular chloride accumulation, and dysregulation of proteins critical to chloride homeostasis. A reduction in neuroinhibition and potentiation of excitatory neurotransmission in CA1 pyramidal neurons represent pathological mechanisms that underlie seizure clusters. Benzodiazepines are well-established treatments for seizure clusters; however, there remain barriers to appropriate care. At the clinical level, there is variability in seizure cluster definitions, such as the number and/or type of seizures associated with a cluster as well as the interictal duration between seizures. This can lead to delays in diagnosis and timely treatment. There are gaps in understanding between clinicians, their patients, and caregivers regarding acute treatment for seizure clusters, such as the use of rescue medications and emergency services. This lack of consensus to define seizure clusters in addition to a lack of education for appropriate treatment can affect quality of life for patients and place a greater burden on patient families and caregivers. For patients with seizure clusters, the sense of unpredictability can lead to continuous traumatic stress, during which patients and families live with a heightened level of anxiety. Clinicians can affect patient quality of life and clinical outcomes through improved seizure cluster education and treatment, such as the development and implementation of a personalized seizure action plan as well as prescriptions for suitable rescue medications indicated for seizure clusters and instructions for their proper use. In all, the combination of targeted therapy along with patient education and support can improve quality of life.
- Open Access
- 1 October 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 123, 108264
Recommendations for development of acute seizure action plans (ASAPs) from an expert panel
- 1 October 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 123, 108264
Open AccessRecommendations for development of acute seizure action plans (ASAPs) from an expert panel
- 5 April 2016
- Published by Wolters Kluwer Health in Neurology
- Vol. 86 (16_supplem)
Experiences with Premorbid SUDEP Discussion among Participants in the North American SUDEP Registry (NASR) (P6.361)
- 5 April 2016
- Published by Wolters Kluwer Health in Neurology
- Vol. 86 (16_supplem)
Experiences with Premorbid SUDEP Discussion among Participants in the North American SUDEP Registry (NASR) (P6.361)